Posts Feed
Comments Feed

Archive for the 'Acid Reflux/GERD' Category

New Test Could Aid Children Suffering From Reflux Disease

A nuclear medicine imaging test was used to confirm that children with respiratory problems may be more likely to develop gastroesophageal reflux disease, according to researchers at SNM’s 55th Annual Meeting. The nuclear imaging technique, known as scintigraphy, was also shown to be more effective in detecting the disease in these children than traditional barium X-ray technology.

More: continued here

No Comments »

Revolutionary Non-Invasive Surgery For Acid Reflux Disease Now Available At Mercy Medical Center

Mercy Medical Center has become the first hospital in the Northeast to offer a new, revolutionary non-invasive procedure that surgically treats chronic heartburn resulting from GastroEsophageal Reflux Disease (GERD).

More: continued here

No Comments »

Cutting Edge Acid Reflux Test Patient-Friendly And Accurate, Improving Diagnosis And Treatment - Restech Dx-pH Measurement System Adopted By CCENT

The Restech Corporation announced that the Central California Ear, Nose & Throat Medical Group (CCENT) of Fresno, California, has adopted the Restech Dx-pH Measurement System to detect acid reflux in the throat. An alarming increase in the incidence of gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux disease (LPRD) in Americans has led to the need for accurate diagnosis of acid reflux as provided by this system.

More: continued here

No Comments »

Santarus Announces Development Program For New ZEGERID Prescription Product

Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, announced that it is developing a new tablet formulation to add to its ZEGERIDŽ family of branded prescription pharmaceutical products. The new formulation is a swallowable tablet that combines immediate-release omeprazole, a proton pump inhibitor (PPI), with a mix of buffers. Santarus plans to undertake clinical and stability studies with the tablet in preparation for the submission of a New Drug Application to the U.S.

More: continued here

No Comments »

TAK-390MR Phase 3 Data Presented At Digestive Disease Week

TAP Pharmaceutical Products Inc. have reported results from three pivotal Phase 3 studies evaluating investigational new drug TAK-390MR, the first proton pump inhibitor (PPI) with an innovative dual delayed release technology, in healing patients with erosive esophagitis (EE) and in maintenance of healed EE. The data were presented at the Digestive Disease Week (DDW) annual meeting in San Diego.

More: continued here

No Comments »

MGH Study Confirms Benefit Of Surgery For Gastroesophageal Reflux

Despite the growing availability of prescription and over-the-counter medications for gastroesophageal reflux disease (GERD), surgical treatment remains a viable alternative for patients whose symptoms persist. In the May 2008 Archives of Surgery, surgeons from Massachusetts General Hospital (MGH) report their survey of almost 200 patients who had laparoscopic antireflux surgery at the MGH over a 10-year period.

More: continued here

No Comments »

The Features Of Chinese Patients With Reflux Esophagitis

Gastroesophageal reflux disease (GERD) is described as the chronic symptoms and/or tissue damage caused by the reflux of abnormal gastric contents to the esophagus. GERD is a common disease, with associated typical symptoms of heartburn and regurgitation.An article published in the World Journal of Gastroenterology evaluated the clinical and endoscopic features in Chinese patients with reflux esophagitis. This study was conducted by Dr.

More: continued here

No Comments »

Researcher Reports On Noninvasive Device For GERD, Obesity

A new, noninvasive gastroplasty device to treat two separate disorders gastroesophageal-reflux disease (GERD) and morbid obesity was reported by its inventor, Charles J. Filipi, M.D., professor of surgery at Creighton University School of Medicine.Filipi spoke about the device, which could be available for human trials later this year, on Monday, May 19, at the 49th annual Digestive Disease Week in San Diego, Calif.

More: continued here

No Comments »

Recurring Symptoms Experienced By Nearly 40 Percent Of GERD Patients Taking PPIs

Despite daily use of doctor-recommended proton pump inhibitors (PPIs) to control gastroesophageal reflux disease (GERD) symptoms, nearly 40 percent of patients who take them continue to experience breakthrough, which is a return of GERD symptoms, such as acid regurgitation and heartburn.

More: continued here

No Comments »

New Advice On Treating GERD: Johns Hopkins Health Alerts Reports On The Latest Research

Johns Hopkins Health Alerts has just published a review of the new GERD guidelines, for safe, effective treatment of your acid reflux. Treating GERD EffectivelyThere are four types of treatments for gastroesophageal reflux disease (GERD): lifestyle measures, medication, surgery, and endoscopic procedures. Why it is important to treat GERDTreating GERD is important.

More: continued here

No Comments »

« Prev - Next »

1